We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$173M
AUM Growth
+$73.3M
Cap. Flow
+$11.6M
Cap. Flow %
6.67%
Top 10 Hldgs %
96.13%
Holding
83
New
26
Increased
11
Reduced
13
Closed
29

Top Buys

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$3.94M
2
FMTO
Femto Technologies Inc. Common Stock
FMTO
+$2.65M
3
ELTK icon
Eltek
ELTK
+$1.68M
4
RDHL
Redhill Biopharma
RDHL
+$1.65M
5
GMM icon
Global Mofy Metaverse
GMM
+$1.57M

Top Sells

Rank Stock Value
1
MMAT
Meta Materials Inc. Common Stock
MMAT
+$904K
2
PHUN icon
Phunware
PHUN
+$821K
3
CYN icon
Cyngn
CYN
+$507K
4
TGL icon
Treasure Global
TGL
+$426K
5
DUO
Fangdd Network Group
DUO
+$392K

Sector Composition

Rank Sector Weight
1 Healthcare 5.65%
2 Technology 1.24%
3 Materials 0.46%
4 Industrials 0.37%
5 Energy 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUCYW icon
51
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$60.6K
$5.24K ﹤0.01%
+103,798
New +$7.75K
NEXRW
52
Nexera Technologies Ltd Warrant
NEXRW
$4.48K ﹤0.01%
76,646
-636
-0.8% -$51
SNES icon
53
SenesTech
SNES
$7.11M
$4.27K ﹤0.01%
+626
New +$5.89K
GWAV icon
54
Greenwave Technology Solutions
GWAV
$2.06M
– –
-4
Closed -$42K
AIRE icon
55
reAlpha
AIRE
$7.56M
– –
-7,430
Closed -$370K
ANY icon
56
CALL
Sphere 3D
ANY
$16.8M
– –
-57
Closed -$186K
APVO icon
57
Aptevo Therapeutics
APVO
$5.25M
– –
-1
Closed -$63.3K
ARQQ icon
58
Arqit Quantum
ARQQ
$305M
– –
-793
Closed -$9.39K
ASTI icon
59
Ascent Solar Technologies
ASTI
$28.9M
– –
-3,594
Closed -$313K
BTCT icon
60
BTC Digital
BTCT
$8.46M
– –
-29,073
Closed -$140K
CYN icon
61
Cyngn
CYN
$15.7M
– –
-234
Closed -$507K
DUO
62
Fangdd Network Group
DUO
$23.4M
– –
-36,375
Closed -$392K
IFBD icon
63
Infobird
IFBD
$9.09M
– –
-2,500
Closed -$26.2K
MAIA icon
64
MAIA Biotechnology
MAIA
$75.4M
– –
-130,510
Closed -$153K
NCRA icon
65
Nocera
NCRA
$2.23M
– –
-951
Closed -$37.7K
OPTT icon
66
Ocean Power Technologies
OPTT
$38.4M
– –
-26,597
Closed -$8.4K
PHIO icon
67
Phio Pharmaceuticals
PHIO
$11.7M
– –
-19,188
Closed -$131K
PHUN icon
68
Phunware
PHUN
$43.8M
– –
-200,132
Closed -$821K
PMCB icon
69
PharmaCyte Biotech
PMCB
$6.33M
– –
-82,373
Closed -$178K
PULM icon
70
Pulmatrix
PULM
$6.14M
– –
-54,188
Closed -$101K
REVB icon
71
Revelation Biosciences
REVB
$4.06M
– –
-70
Closed -$202K
TGL icon
72
Treasure Global
TGL
$6.2M
– –
-68
Closed -$426K
AUMN
73
DELISTED
Golden Minerals Company
AUMN
– –
-190,022
Closed -$98.8K
MMAT
74
DELISTED
Meta Materials Inc. Common Stock
MMAT
– –
-137,021
Closed -$904K
EFTR
75
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
– –
-4,000
Closed -$46.7K
1 2
3
4

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sabby Management held 83 positions worth $173M, up 73% from $100M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Sabby Management deployed $11.6M of net new capital in Q1 2024, opening 26 new positions and adding to 11 existing holdings. Its largest new stake was Vivani Medical: 2,673,018 shares worth $4.95M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 3.8% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Akari Therapeutics, an estimated $279K trimmed.

  • Sabby Management's largest Q1 2024 buy was Vivani Medical: 2,673,018 shares worth $4.95M.
  • Sabby Management added most to Femto Technologies Inc. Common Stock in Q1 2024, an estimated $2.65M increase.
  • Sabby Management's biggest Q1 2024 reduction was Akari Therapeutics, cutting an estimated $279K.
  • Sabby Management fully exited Meta Materials Inc. Common Stock in Q1 2024, selling an estimated $904K.
  • Sabby Management's ten largest holdings make up 96% of its $173M portfolio in Q1 2024.
  • Sabby Management opened 26 new positions and closed 29 in Q1 2024.
  • Sabby Management's portfolio value rose 73% quarter-over-quarter to $173M.

Based on Sabby Management's 13F filing for Q1 2024, filed 15 May 2024.